You are here Home Guidance and resources Sponsors Gilead Sciences Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian Public Assessment Report (AusPAR) (1) Date 2019 (1) Results for "[search-keyword]" Search Sponsor content1 result(s) found, displaying 1 to 1 AusPAR: Bictegravir / emtricitabine / tenofovir alafenamide 1 August 2019 Australian Public Assessment Report (AusPAR) Australian Public Assessment for Bictegravir / emtricitabine / tenofovir alafenamide
AusPAR: Bictegravir / emtricitabine / tenofovir alafenamide 1 August 2019 Australian Public Assessment Report (AusPAR) Australian Public Assessment for Bictegravir / emtricitabine / tenofovir alafenamide